REGN88
6R88-RA-0802
Phase 1 mab completed
Quick answer
REGN88 for Rheumatoid Arthritis is a Phase 1 program (mab) at REGENERON PHARMACEUTICALS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 1
- Modality
- mab
- Status
- completed